pharma · Solid Tumor, Adult · Solid Tumor · CTMX
CytomX Therapeutics
CytomX Therapeutics clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Employees
- 98
- Programs
- 8
- Drugs
- 0
- Patents
- 62
CytomX Therapeutics projects
8 ClinicalTrials.gov programs sponsored by CytomX Therapeutics.
CytomX Therapeutics has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
CX-072
CytomX Therapeutics
Solid Tumor
2 trials -
CX-2009
CytomX Therapeutics
Solid Tumor, Adult
1 trial -
CX-2009
CytomX Therapeutics
Neoplasms
1 trial -
CX-2029
CytomX Therapeutics
Solid Tumor, Adult
1 trial -
CX-188
CytomX Therapeutics
Solid Tumor, Adult
1 trial -
CX-2051
CytomX Therapeutics
Solid Tumor, Adult
1 trial -
CX-801
CytomX Therapeutics
Solid Tumor, Adult
1 trial -
CX-904
CytomX Therapeutics
Solid Tumors
1 trial
Frequently asked questions
How many clinical projects does CytomX Therapeutics have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.